Chicago – Medical device companies are now tapping into the growing popularity of wearable health technology by introducing sensors that track glucose levels. Abbott Laboratories, known for its smartwatches and smart rings, has launched a new device called Lingo that is aimed at health enthusiasts who want to monitor their glucose levels, even if they don’t have diabetes.
Abbott’s Lingo biosensor is worn on the back of the upper arm and measures glucose levels in the body’s interstitial fluid. Users can track their glucose levels, log meals, exercise, and receive personalized recommendations through an app on their phones. The device, which lasts for 14 days and then needs to be replaced, is available for purchase with different pricing options.
Competitor Dexcom has also released a similar device for both diabetics and nondiabetics who do not take insulin, called Stelo. With these devices, Abbott and Dexcom are moving beyond the diabetes devices market and into the wearable wellness market. However, affordability remains a concern, as not everyone may be able to pay for the devices.
Experts caution that while continuous glucose monitoring devices have potential benefits for people without diabetes, it is still unclear whether they improve health long-term. There is a concern that the devices may cause unnecessary anxiety about health for some users. Despite these uncertainties, many believe that these sensors have the potential to help individuals be proactive about their health and make more informed lifestyle choices.
Source
Photo credit www.uniondemocrat.com